PRM53 - THE USE OF PROXY MARKERS TO DEFINE DISEASE STAGE IN PATIENTS WITH MALIGNANT MELANOMA- AN OBSERVATIONAL STUDY USING THE HOSPITAL EPISODE STATISTICS (HES) DATABASE IN ENGLAND

Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2175
https://www.valueinhealthjournal.com/article/S1098-3015(18)35477-9/fulltext
Title : PRM53 - THE USE OF PROXY MARKERS TO DEFINE DISEASE STAGE IN PATIENTS WITH MALIGNANT MELANOMA- AN OBSERVATIONAL STUDY USING THE HOSPITAL EPISODE STATISTICS (HES) DATABASE IN ENGLAND
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35477-9&doi=10.1016/j.jval.2018.09.2175
First page :
Section Title :
Open access? : No
Section Order : 1521
Categories :
Tags :
Regions :
ViH Article Tags :